BrainStorm Cell Therapeutics Inc. Elects Moshe Lion to Its Board of Directors

NEW YORK & PETACH TIKVAH, Israel--(BUSINESS WIRE)--BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, announced today the election of Moshe Lion to the Company’s Board of Directors.

MORE ON THIS TOPIC